Dolinnov
Biotechnology Research • 
Montpellier, Occitanie, France • 1-10 Employees
Company overview
| Headquarters | 418, Rue du Mas de Verchant, Montpellier, Occitanie 34170, FR |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Pain Management, Cipn, Aso Therapy |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Key Contact at Dolinnov
Grégoire Serra
Founder & CEO
Dolinnov Email Formats
Dolinnov uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@dolinnov.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@dolinnov.com | 100% |
About Dolinnov
Dolinnov is a french preclinical research company dedicated to advancing solutions for chronic pain management, driven by a passion for science and innovation. Our mission is to improve patients’ lives by delivering cutting-edge solutions for severe and unbearable conditions. Leveraging our proprietary conjugated L-ASO technology, we design targeted, effective, and safer therapies. This breakthrough approach directly addresses the root causes of pain through precise molecular interventions, providing hope to those enduring chemotherapy-induced pain and other challenging conditions.
Dolinnov revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Dolinnov has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Dolinnov has never raised funding before.
United States
Spain
Canada
United Kingdom
South Africa
Frequently asked questions
4.8
40,000 users
